According to the researchers, up to 85.1% of those treated with survodutide achieved at least a 5% reduction in their weight, contrasting with only 38.8% in the placebo group who reached this goal
By following a tailored approach, CMD can adjust the peptide selection, administration schedule, dosing, and treatment duration
The newer binders, sodium zirconium cyclosilicate, and patiromer, facilitate optimization of RAAS blockage therapy and have supportive evidence
It is worth noting that the oral formulation of semaglutide (Rybelsus) does require specific administration instructions, including taking it on an empty stomach with no more than 4 ounces of water and waiting 30 minutes before eating, drinking, or taking other oral medications